Increased sCD163 has been shown in obesity [22, 23], metabolic dysregulation and visceral adiposity [24], and is considered a marker of insulin resistance and future T2DM [25, 26]. Here, CD163 is linked to obesity due to melanocortin 4 receptor deficiency.